What stands out
This is a meaningful pathway in the sample.
Report Explainer
This page explains why this pathway rose in the sample report, what it likely means, and what to validate next.
This is a meaningful pathway in the sample.
The working read here is lower insulin sensitivity support.
Fasting insulin, HOMA-IR, C-peptide
High. This is one of the clearest and most testable findings in the report.
Why it rose
This pathway tends to surface when several studied variants in its core genes point in a similar direction strongly enough to justify biomarker follow-up.
shows how much insulin support the body is using in the fasting state
HOMA-IR gives practical context for whether insulin sensitivity is showing up in real physiology.
C-peptide gives practical context for whether insulin sensitivity is showing up in real physiology.
Main genes
INSR adds weight to the same pathway interpretation, but does not drive it alone.
INSR adds insulin sensitivity context and should be interpreted with the surrounding pathway pattern, not on its own.
IRS2 adds weight to the same pathway interpretation, but does not drive it alone.
IRS2 adds insulin sensitivity context and should be interpreted with the surrounding pathway pattern, not on its own.
AKT2 adds weight to the same pathway interpretation, but does not drive it alone.
AKT2 adds insulin sensitivity context and should be interpreted with the surrounding pathway pattern, not on its own.
ENPP1 adds weight to the same pathway interpretation, but does not drive it alone.
ENPP1 adds insulin sensitivity context and should be interpreted with the surrounding pathway pattern, not on its own.